إعلان
إعلان

ICCM

ICCM logo

IceCure Medical Ltd. Ordinary Shares

0.69
USD
برعاية
+0.02
+2.93%
٠٧ يناير, ١٥:٥٨ UTC -5
مغلق
exchange

بعد الإغلاق

0.69

0.00
+0.29%

تقارير أرباح ICCM

النسبة الإيجابية المفاجئة

ICCM تفوق 10 من 14 آخر التقديرات.

71%

التقرير التالي

بيانات التقرير القادم
٠٣ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$1.73M
/
-$0.04
التغير الضمني من Q3 25 (Revenue/ EPS)
+104.06%
/
-33.33%
التغير الضمني من Q4 24 (Revenue/ EPS)
+98.23%
/
-50.00%

IceCure Medical Ltd. Ordinary Shares earnings per share and revenue

On ١٩ نوفمبر ٢٠٢٥, ICCM reported earnings of -0.06 USD per share (EPS) for Q3 25, missing the estimate of -0.05 USD, resulting in a -17.65% surprise. Revenue reached 850.00 ألف, compared to an expected 728.28 ألف, with a 16.71% difference. The market reacted with a -3.21% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 المحللين forecast an EPS of -0.04 USD, with revenue projected to reach 1.73 مليون USD, implying an نقصان of -33.33% EPS, and زيادة of 104.06% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, IceCure Medical Ltd. Ordinary Shares reported EPS of -$0.06, missing estimates by -17.65%, and revenue of $850.00K, 16.71% above expectations.
The stock price moved down -3.21%, changed from $0.72 before the earnings release to $0.70 the day after.
The next earning report is scheduled for ٠٣ مارس ٢٠٢٦.
Based on 4 المحللين, IceCure Medical Ltd. Ordinary Shares is expected to report EPS of -$0.04 and revenue of $1.73M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان